STOK
Stoke Therapeutics, Inc.$33.49-0.22 (-0.65%)Prev Close$33.71·MCap$2.11B·P/E—·Vol217.7K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
35
$12.13M
◆
Net Activity
Net Seller
$12.13M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Stoke Therapeutics, Inc. (STOK) has been exclusively selling, with 0 insider purchases totaling $0.00 and 35 insider sales totaling $12.13M. The most recent insider transaction was by Ticho Barry (officer: CHIEF MEDICAL OFFICER), who sold $60.0K worth of shares on Apr 3, 2026. Stoke Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.11B.
STOK Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 3, 2026 | Ticho Barry | officer: CHIEF MEDICAL OFFICER | Sell | 1,838 | $32.66 | $60.0K | 38,864 |
| Mar 24, 2026 | Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | Sell | 9,293 | $33.69 | $313.0K | 20,144-32% |
| Mar 19, 2026 | Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | Sell | 8,895 | $32.14 | $285.9K | 35,255 |
| Mar 19, 2026 | Hoitt Jason | officer: Chief Patient Officer | Sell | 3,712 | $32.14 | $119.3K | 12,955 |
| Mar 19, 2026 | Leggett Thomas | officer: Chief Financial Officer | Sell | 4,578 | $32.14 | $147.1K | 13,476-25% |
| Mar 19, 2026 | Ticho Barry | officer: CHIEF MEDICAL OFFICER | Sell | 14,311 | $31.92 | $456.8K | 50,071 |
| Mar 17, 2026 | LEVIN ARTHUR A | director | Sell | 605 | $36.80 | $22.3K | 4,237 |
| Mar 12, 2026 | Krainer Adrian R. | director | Sell | 33,243 | $39.74 | $1.32M | 283,302 |
| Mar 12, 2026 | TZIANABOS ARTHUR | director, officer: Interim Executive Chair | Sell | 4,355 | $40.00 | $174.2K | 31,339 |
| Dec 8, 2025 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 3,978 | $32.28 | $128.4K | 0 |
| Dec 8, 2025 | Kaye Edward M. MD | Director | Sell | 13,430 | $32.27 | $433.4K | 0 |
| Dec 3, 2025 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 9,803 | $31.25 | $306.3K | 0 |
| Dec 3, 2025 | Kaye Edward M. MD | Director | Sell | 15,001 | $31.13 | $467.0K | 0 |
| Dec 3, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 5,358 | $31.19 | $167.1K | 0 |
| Dec 1, 2025 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 4,576 | $30.22 | $138.3K | 0 |
| Dec 1, 2025 | Kaye Edward M. MD | Director | Sell | 2,136 | $30.22 | $64.5K | 0 |
| Dec 1, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 4,020 | $30.22 | $121.5K | 0 |
| Nov 24, 2025 | Krainer Adrian R. | Director | Sell | 40,472 | $29.72 | $1.20M | 0 |
| Nov 14, 2025 | Krainer Adrian R. | Director | Sell | 40,472 | $26.98 | $1.09M | 0 |
| Nov 3, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 5,931 | $25.72 | $152.6K | 0 |
| Oct 8, 2025 | Kaye Edward M. MD | Director | Sell | 25,000 | $30.00 | $750.0K | 0 |
| Oct 3, 2025 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 10,000 | $25.07 | $250.7K | 0 |
| Oct 3, 2025 | Kaye Edward M. MD | Director | Sell | 42,461 | $25.09 | $1.07M | 0 |
| Oct 1, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 5,343 | $23.64 | $126.3K | 0 |
| Sep 2, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 5,501 | $19.87 | $109.3K | 0 |
| Aug 29, 2025 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 22,117 | $20.11 | $444.8K | 0 |
| Aug 29, 2025 | Kaye Edward M. MD | Director | Sell | 61,885 | $20.13 | $1.25M | 0 |
| Aug 18, 2025 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 1,683 | $18.24 | $30.7K | 0 |
| Aug 18, 2025 | Kaye Edward M. MD | Director | Sell | 12,126 | $18.24 | $221.2K | 0 |
| Aug 18, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 2,805 | $18.24 | $51.2K | 0 |
| Aug 13, 2025 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 13,712 | $15.00 | $205.7K | 0 |
| Aug 1, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 4,504 | $12.82 | $57.7K | 0 |
| Jul 1, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 4,503 | $11.63 | $52.4K | 0 |
| Jun 2, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 8,216 | $10.02 | $82.3K | 0 |
| May 1, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 26,631 | $10.02 | $267.0K | 0 |
| Mar 18, 2025 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 4,211 | $8.49 | $35.7K | 0 |
| Mar 18, 2025 | Kaye Edward M. MD | Director | Sell | 19,289 | $8.49 | $163.7K | 0 |
| Mar 18, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 7,217 | $8.49 | $61.2K | 0 |
| Nov 5, 2024 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 10,000 | $12.68 | $126.8K | 2,485-80% |
| Oct 2, 2024 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 10,000 | $12.06 | $120.6K | 2,485-80% |
| Sep 23, 2024 | Skorpios Trust | 10% Owner | Sell | 1,937,500 | $14.05 | $27.22M3.3% OS | 8,906,181 |
| Sep 5, 2024 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 10,000 | $14.95 | $149.5K | 3,085-76% |
| Aug 5, 2024 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 10,000 | $14.58 | $145.8K | 2,485-80% |
| Jul 3, 2024 | Nash Huw M. | Chief Business Officer | Sell | 2,500 | $13.11 | $32.8K | 33-99% |
| Jul 3, 2024 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 10,000 | $13.75 | $137.5K | 2,485-80% |
| Jun 5, 2024 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 10,000 | $15.22 | $152.2K | 2,588-79% |
| May 22, 2024 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 8,599 | $15.04 | $129.3K | 2,598-77% |
| May 22, 2024 | Kaye Edward M. MD | CEO | Sell | 42,350 | $15.43 | $653.5K | 29,664-59% |
| May 22, 2024 | Nash Huw M. | COO & CBO | Sell | 50,000 | $15.39 | $769.5K | 0Exit |
| May 3, 2024 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 10,000 | $11.37 | $113.7K | 2,485-80% |
Showing 1–50 of 80
1 / 2
STOK Insider Buying Activity
The following table shows recent insider purchases of Stoke Therapeutics, Inc. (STOK) stock reported via SEC Form 4 filings.
No insider buying activity found for STOK in the last 12 months.
STOK Insider Selling Activity
The following table shows recent insider sales of Stoke Therapeutics, Inc. (STOK) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Apr 3, 2026 | Ticho Barry | officer: CHIEF MEDICAL OFFICER | Sell | 1,838 | $32.66 | $60.0K | 38,864 |
| Mar 24, 2026 | Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | Sell | 9,293 | $33.69 | $313.0K | 20,144-32% |
| Mar 19, 2026 | Allan Jonathan | officer: GENERAL COUNSEL & CORP SEC | Sell | 8,895 | $32.14 | $285.9K | 35,255 |
| Mar 19, 2026 | Hoitt Jason | officer: Chief Patient Officer | Sell | 3,712 | $32.14 | $119.3K | 12,955 |
| Mar 19, 2026 | Leggett Thomas | officer: Chief Financial Officer | Sell | 4,578 | $32.14 | $147.1K | 13,476-25% |
| Mar 19, 2026 | Ticho Barry | officer: CHIEF MEDICAL OFFICER | Sell | 14,311 | $31.92 | $456.8K | 50,071 |
| Mar 17, 2026 | LEVIN ARTHUR A | director | Sell | 605 | $36.80 | $22.3K | 4,237 |
| Mar 12, 2026 | Krainer Adrian R. | director | Sell | 33,243 | $39.74 | $1.32M | 283,302 |
| Mar 12, 2026 | TZIANABOS ARTHUR | director, officer: Interim Executive Chair | Sell | 4,355 | $40.00 | $174.2K | 31,339 |
| Dec 8, 2025 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 3,978 | $32.28 | $128.4K | 0 |
| Dec 8, 2025 | Kaye Edward M. MD | Director | Sell | 13,430 | $32.27 | $433.4K | 0 |
| Dec 3, 2025 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 9,803 | $31.25 | $306.3K | 0 |
| Dec 3, 2025 | Kaye Edward M. MD | Director | Sell | 15,001 | $31.13 | $467.0K | 0 |
| Dec 3, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 5,358 | $31.19 | $167.1K | 0 |
| Dec 1, 2025 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 4,576 | $30.22 | $138.3K | 0 |
| Dec 1, 2025 | Kaye Edward M. MD | Director | Sell | 2,136 | $30.22 | $64.5K | 0 |
| Dec 1, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 4,020 | $30.22 | $121.5K | 0 |
| Nov 24, 2025 | Krainer Adrian R. | Director | Sell | 40,472 | $29.72 | $1.20M | 0 |
| Nov 14, 2025 | Krainer Adrian R. | Director | Sell | 40,472 | $26.98 | $1.09M | 0 |
| Nov 3, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 5,931 | $25.72 | $152.6K | 0 |
| Oct 8, 2025 | Kaye Edward M. MD | Director | Sell | 25,000 | $30.00 | $750.0K | 0 |
| Oct 3, 2025 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 10,000 | $25.07 | $250.7K | 0 |
| Oct 3, 2025 | Kaye Edward M. MD | Director | Sell | 42,461 | $25.09 | $1.07M | 0 |
| Oct 1, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 5,343 | $23.64 | $126.3K | 0 |
| Sep 2, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 5,501 | $19.87 | $109.3K | 0 |
| Aug 29, 2025 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 22,117 | $20.11 | $444.8K | 0 |
| Aug 29, 2025 | Kaye Edward M. MD | Director | Sell | 61,885 | $20.13 | $1.25M | 0 |
| Aug 18, 2025 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 1,683 | $18.24 | $30.7K | 0 |
| Aug 18, 2025 | Kaye Edward M. MD | Director | Sell | 12,126 | $18.24 | $221.2K | 0 |
| Aug 18, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 2,805 | $18.24 | $51.2K | 0 |
| Aug 13, 2025 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 13,712 | $15.00 | $205.7K | 0 |
| Aug 1, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 4,504 | $12.82 | $57.7K | 0 |
| Jul 1, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 4,503 | $11.63 | $52.4K | 0 |
| Jun 2, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 8,216 | $10.02 | $82.3K | 0 |
| May 1, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 26,631 | $10.02 | $267.0K | 0 |
| Mar 18, 2025 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 4,211 | $8.49 | $35.7K | 0 |
| Mar 18, 2025 | Kaye Edward M. MD | Director | Sell | 19,289 | $8.49 | $163.7K | 0 |
| Mar 18, 2025 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 7,217 | $8.49 | $61.2K | 0 |
| Nov 5, 2024 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 10,000 | $12.68 | $126.8K | 2,485-80% |
| Oct 2, 2024 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 10,000 | $12.06 | $120.6K | 2,485-80% |
| Sep 23, 2024 | Skorpios Trust | 10% Owner | Sell | 1,937,500 | $14.05 | $27.22M3.3% OS | 8,906,181 |
| Sep 5, 2024 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 10,000 | $14.95 | $149.5K | 3,085-76% |
| Aug 5, 2024 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 10,000 | $14.58 | $145.8K | 2,485-80% |
| Jul 3, 2024 | Nash Huw M. | Chief Business Officer | Sell | 2,500 | $13.11 | $32.8K | 33-99% |
| Jul 3, 2024 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 10,000 | $13.75 | $137.5K | 2,485-80% |
| Jun 5, 2024 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 10,000 | $15.22 | $152.2K | 2,588-79% |
| May 22, 2024 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | 8,599 | $15.04 | $129.3K | 2,598-77% |
| May 22, 2024 | Kaye Edward M. MD | CEO | Sell | 42,350 | $15.43 | $653.5K | 29,664-59% |
| May 22, 2024 | Nash Huw M. | COO & CBO | Sell | 50,000 | $15.39 | $769.5K | 0Exit |
| May 3, 2024 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | 10,000 | $11.37 | $113.7K | 2,485-80% |
STOK Insiders
Similar Stocks to STOK
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B